Novo Nordisk Says It Will Slash the Price of Insulin
The drug company Novo Nordisk on Tuesday said it would reduce the sticker prices of several of its insulin products by up to 70 percent, reversing years of price increases in the face of mounting pressure. The company did not announce any changes to the out-of-pocket costs for patients with diabetes, but said its existing…
Details